Cancer
Malignant Cervical Neoplasm
CI-CAN-00007992Explore in graph →
Top-level506 active trials4 approved drugs14 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00007992Explore in graph →
Clinical trials
1,994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (181)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03104699 | A Study of AGEN2034 in Advanced Tumors and Cervical Cancer | completed | Phase 1 / Phase 2 | 211 | Agenus Inc.INDUSTRY | 9 | Jul 30, 2025 | clinicaltrials |
| NCT03444376 | The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer | completed | Phase 1 / Phase 2 | 65 | Genexine, Inc.INDUSTRY | 1 | Jul 30, 2025 | clinicaltrials |
| Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma(ECWHCCFLACC) |
| completed |
| Phase 2 |
| 120 |
| Yong Zhang,MDOTHER |
| 1 |
| Jul 29, 2025 |
| clinicaltrials |
| NCT07070687 | Transcutaneous Electrical Nerve Stimulation in Nerve-Sparing Radical Hysterectomy: Effects on Bladder Management and Quality of Life in Cervical Cancer | completed | N/A | 78 | Fudan UniversityOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT04242199 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors | completed | Phase 1 | 182 | Incyte CorporationINDUSTRY | 5 | Jul 14, 2025 | clinicaltrials |
| NCT05453006 | HPV Self-Sampling in Somali Women (Isbaar Project)(Isbaar) | completed | N/A | 3,367 | University of MinnesotaOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT02635360 | Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer | completed | Phase 2 | 94 | Linda R DuskaOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT04461678 | Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay Kit | completed | N/A | 12,230 | Becton, Dickinson and CompanyINDUSTRY | 1 | Jul 2, 2025 | clinicaltrials |
| NCT01226316 | Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules | completed | Phase 1 | 285 | AstraZenecaINDUSTRY | 10 | Jun 29, 2025 | clinicaltrials |
| NCT03357757 | Avelumab With Valproic Acid in Virus-associated Cancer(LATENT) | completed | Phase 2 | 39 | AHS Cancer Control AlbertaOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT04998318 | 1:1 Comparison of the Pocket Colposcope in Kenya | completed | N/A | 434 | Duke UniversityOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT01351103 | A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands | completed | Phase 1 | 185 | Novartis PharmaceuticalsINDUSTRY | 7 | Jun 13, 2025 | clinicaltrials |
| NCT03542513 | First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN) | completed | — | 65 | Universiteit AntwerpenOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT03826589 | Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy(ALARICE) | completed | N/A | 23 | The University of Hong KongOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT05939440 | Interventions to Decrease Financial Toxicity(P-COC) | completed | N/A | 60 | University of Alabama at BirminghamOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT03108131 | Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors | completed | Phase 2 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT02713386 | Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 1 / Phase 2 | 147 | NRG OncologyOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT03994055 | Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer | completed | N/A | 136 | National Institute of CancerologíaOTHER_GOV | 1 | May 25, 2025 | clinicaltrials |
| NCT01101451 | Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery | completed | Phase 3 | 340 | GOG FoundationNETWORK | 3 | May 23, 2025 | clinicaltrials |
| NCT03508570 | Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis | completed | Phase 1 | 26 | M.D. Anderson Cancer CenterOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT06984289 | US Radiomics in Advanced Cervical Cancer(RU-LACC) | completed | — | 220 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT06284447 | Barriers to Cervical Cancer Screening | completed | — | 2,216 | Mayo ClinicOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06562595 | What is the Optimal Training Model for Cervical Awareness? | completed | N/A | 400 | Izmir City HospitalOTHER_GOV | 1 | May 20, 2025 | clinicaltrials |
| NCT03198286 | Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors | completed | N/A | 40 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT04821297 | Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results | completed | N/A | 30 | Thomas Jefferson UniversityOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT06915779 | Long Term Follow-up of HPV Vaccine in HIV (CTN 236) | completed | — | 241 | University of British ColumbiaOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT04925284 | Study of XB002 in Subjects With Solid Tumors (JEWEL-101) | completed | Phase 1 | 269 | ExelixisINDUSTRY | 9 | Apr 4, 2025 | clinicaltrials |
| NCT03894618 | SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 49 | Shattuck Labs, Inc.INDUSTRY | 4 | Apr 2, 2025 | clinicaltrials |
| NCT03749707 | HPV in Sentinel Lymph Nodes of Cervical Cancer Patients | completed | N/A | 127 | University of AarhusOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT06897306 | Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study | completed | — | 317 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT02684227 | Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer | completed | Phase 2 | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT04499521 | A Randomized Study to Compare a Hydrogel Packing System to Standard Packing During HDR Brachytherapy for Cervical Cancer | completed | N/A | 21 | University of VirginiaOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT06149598 | Coughing at Time of Cervical Biopsy | completed | N/A | 30 | Zydolab - Institute of Cytology and Immune CytochemistryOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT04380805 | A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer | completed | Phase 2 | 30 | AkesoINDUSTRY | 3 | Feb 28, 2025 | clinicaltrials |
| NCT04951921 | Hyperpolarized 13C Pyruvate MRI for Early Immune Evaluation in Cervical Cancer Patients At Baseline and CCRT Therapy | completed | Phase 2 | 6 | Chang Gung Memorial HospitalOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06823817 | Quality Control of Colposcopy Application(QCCA) | completed | — | 10,000 | Peking Union Medical College HospitalOTHER | 0 | Feb 12, 2025 | clinicaltrials |
| NCT01652196 | Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer | completed | Phase 2 | 56 | John HaysOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT01814501 | Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab | completed | Phase 2 | 16 | John HaysOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT04492007 | Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS)(PRISMS) | completed | N/A | 46 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT04508309 | Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (Cecolin®) in Young Girls | completed | Phase 3 | 1,025 | PATHOTHER | 2 | Jan 30, 2025 | clinicaltrials |
| NCT05474404 | Telecytology as a Triage Tool in LMICs | completed | — | 30 | University Hospital, GenevaOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT03483610 | Promoting Cervical Cancer Screening for Emergency Department Patients | completed | N/A | 95 | University of RochesterOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT04275713 | Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC(METOXY-LACC) | completed | Phase 2 | 41 | Oslo University HospitalOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT06781073 | Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma | completed | Phase 3 | 118 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT04086771 | Southeast Asian Women's Health Project | completed | N/A | 194 | Ohio State UniversityOTHER | 1 | Jan 16, 2025 | clinicaltrials |
| NCT03757299 | Promoting Comprehensive Cervical Cancer Prevention and Better Women Health in Cameroon(PCCCP) | completed | N/A | 4,473 | Prof. Patrick PetignatOTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT06166420 | Home-based Cervical Cancer Screening Project(CASAHO) | completed | N/A | 2,079 | Prof. Patrick PetignatOTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT05131581 | Strategies to Improve the Experience of Gynaecological Screening | completed | N/A | 206 | Uppsala UniversityOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT03946358 | Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)(VolATIL) | completed | Phase 2 | 47 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 20, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Jul 30, 2025source: clinicaltrials